AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results

  • 📰 Reuters
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

AstraZeneca beat forecasts over the third quarter, with sales of key cancer medicine Tagrisso and Imfinzi helping take overall revenue to almost $11 billion, ahead of analysts' expectations

Co not affected by geopolitical tensions in China - CEOLifts full-year EPS forecast

The Anglo-Swedish company said it managed to grow its business in China despite protracted COVID lockdowns and was no longer pursuingAstraZeneca is seen as a bellwether for the pharmaceutical sector in China, which accounted for about 16% of the company's total revenue last year. Despite the headwinds, the company generated 8% sales growth in the region on a constant currency basis in the quarter, whereas it had expected a decline, chief executive Pascal Soriot said on a media call.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Scumbags

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines